Therefore, it can be speculated that ANGPTL4 may regulate the cell communication (exp: increased of FA) of ECs-CMs caused by hyperglycemia and become a potential therapeutic target for diabetic cardiomyopathy by regulating lipid metabolism and glucose metabolism. This evidence concerns the gene ANGPTL4 and diabetic cardiomyopathy.